3-TYP

  • CAS
  • Size
  • Purity
  • Price
  • Availability
  • Quantity
  • Order

If you have any other questions or need other size, please get a quote.

Catalog Number
ACM120241794
Product Name
3-TYP
Structure
Structure
CAS
120241-79-4
Category
Inhibitors
Description
3-TYP is an inhibitor of SIRT3.
Synonyms
3-TYP; 3TYP; 3 TYP
IUPAC Name
3-(1H-1,2,3-triazol-4-yl) pyridine
Molecular Weight
146.15
Molecular Formula
C7H6N4
Canonical SMILES
C1(C2=CNN=N2)=CC=CN=C1
InChI
InChI=1S/C7H6N4/c1-2-6(4-8-3-1)7-5-9-11-10-7/h1-5H,(H,9,10,11)
InChI Key
VYXFEFOIYPNBFK-UHFFFAOYSA-N
Solubility
Soluble in DMSO
Appearance
Solid powder
Shelf Life
>2 years if stored properly
Storage
Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Biological Target
3-TYP is a selective SIRT3 inhibitor, with an IC50 of 16 nM, more potent over SIRT1 (IC50=88 nM), SIRT2 (IC50=92 nM).
Drug Formulation
This drug may be formulated in DMSO
Elemental Analysis
C, 57.53; H, 4.14; N, 38.34
Exact Mass
146.0592
HS Tariff Code
2934.99.9001
In Vitro Activity
3-TYP inhibits melatonin-enhanced SIRT3 activity but does not affect SIRT3 protein expression. 3-TYP pretreatment reverses the protective effects of melatonin on cadmium (Cd)-induced mitochondrial-derived O2·- production and autophagic cell death. 3-TYP significantly attenuates melatonin-induced increases in deacetylated-SOD2 expression and SOD2 activity in HepG2 cells exposed to Cd.
Reference: Autophagy. 2015;11(7):1037-51. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26120888/
In Vivo Activity
3-TYP (50 mg/kg, i.p.) does not significantly influence the LVEF, LVFS, infarct size, serum LDH levels, apoptosis, and oxidative stress compared with those of the Sham group. Moreover, 3-TYP has little effect on gp91phox, Nrf2, NQO 1, Bax, Bcl-2, Caspase-3, and cleaved Caspase-3 expression levels, compared with the Sham group. 3-TYP significantly decreases SIRT3 activity and increases the acetylation of SOD2 compared with that in the control group, without influencing SIRT3 expression. 3-TYP attenuates the cardioprotective effects of melatonin by decreasing the LVEF and LVFS after 24 hour of reperfusion. 3-TYP also increases the infarct size, serum LDH levels, and apoptotic ratio compared with those in the IR+Mel group.
Reference: J Pineal Res. 2017 Sep;63(2). https://doi.org/10.1111/jpi.12419
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Stock Solution Storage
0-4 °C for short term (days to weeks), or -20 °C for long term (months).
Please kindly note that our products are for research use only.

Discover More

Contact Us

For product inquiries, please use our online system or send an email to .

Download
Verification code
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.
qrcode